Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Sangamo Therapeutics Inc. logo

Sangamo Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

0.62
 
USD
  
0.02
  
(3.53%)
Optionable: Yes  Market Cap: 108 M  90-day average vol: 2,367,559

Previous close: 0.6034  Open: 0.6057  Bid: 0.62  Ask: 0.6435
52 week range    
0.29   
   1.82
Peers   
ALNY / 
GILD / 
AMGN / 
BIIB / 
BMRN / 
JNJ / 
DOW / 
Last updated: Thursday 28th March 2024
43
MarketXLS Rank
60
Value
30
Technical
39
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Financials

SGMO Cash Flow

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
(Increase) Decrease in other current assets-320000.0
(Increase) Decrease in other current liabilities-2 M13 M-8 M-5 M49 M101 M-32 M218 M-83 M-91 M
(Increase) Decrease in other working capital218000.0
(Increase) Decrease in payables269000.04 M-764000.0-2 M3 M-6 M-4 M11 M-8 M13 M
(Increase) Decrease in receivables860000.0-7 M8 M-2 M2 M-1 M-33 M31 M-103000.02 M
Acquisitions79000.0-2 M-76 M-262000.0-704000.0-119000.0
Amortization of intangibles6 M8 M8 M8 M
AssetImpairmentCharge2 M
CapitalExpenditureReported432000.0621000.02 M732000.04 M43 M21 M15 M23 M20 M
Cash at beginning of period22 M10 M6 M69 M22 M53 M144 M82 M133 M180 M
Cash at end of period10 M6 M69 M22 M53 M144 M82 M-12 M180 M15 M
Cash flow-20 M-6 M-32 M-66 M11 M37 M-144 M170 M-233 M-224 M
CashFlowFromContinuingInvestingActivities-68 M-100 M76 M18 M-77 M-178 M-60 M-272 M248 M59 M
ChangeInAccountPayable269000.04 M-764000.0-2 M3 M-6 M-4 M11 M-8 M13 M
ChangeInPayablesAndAccruedExpense269000.04 M-764000.0-2 M3 M-6 M-4 M11 M-8 M13 M
ChangeInPrepaidAssets-160000.0-258000.0376000.0-1 M-669000.0-3 M-7 M-10 M-7 M-5 M
ChangeInWorkingCapital-2 M10 M-805000.0-11 M53 M91 M-75 M249 M-98 M-81 M
ChangesInAccountReceivables1 M-7 M8 M-2 M2 M-1 M-32 M32 M-789000.02 M
Current deferred income taxes-6 M-14000.0
Deferred income taxes-6 M-14000.0
Depreciation569000.0549000.0988000.0997000.01 M2 M4 M6 M9 M12 M
Depreciation unreconciled1 M2 M2 M1 M825000.0-3 M5 M13 M20 M19 M
DepreciationAndAmortization1 M2 M2 M1 M825000.0-3 M5 M13 M20 M19 M
Effect of exchange rate changes439000.0184000.0-447000.0-263000.01 M
FinancingCashFlow76 M102 M20 M337000.097 M232 M142 M153 M33 M85 M
Free cash flow-20 M-7 M-32 M-67 M7 M-7 M-165 M155 M-257 M-244 M
GainLossOnSaleOfPPE12000.068000.0222000.0-52000.0
Issuance of capital stock9 M13 M7 M1 M17 M1 M2 M145 M
IssuanceOfCapitalStock9 M13 M7 M1 M17 M1 M2 M145 M
Net cash from financing activities76 M102 M20 M337000.097 M232 M142 M9 M2 M-2 M
Net cash from investing activities-68 M-100 M76 M18 M-77 M-178 M-60 M-272 M248 M59 M
Net cash from operating activities-20 M-6 M-32 M-66 M11 M37 M-144 M170 M-233 M-224 M
Net change in cash & cash equivalents-11 M-4 M63 M-47 M31 M91 M-62 M50 M47 M-77 M
Net income from continuing operations-27 M-26 M-41 M-72 M-55 M-69 M-95 M-121 M-178 M-192 M
NetBusinessPurchaseAndSale79000.0-2 M-76 M-262000.0-704000.0-119000.0
NetCommonStockIssuance9 M13 M7 M1 M17 M1 M2 M145 M
NetForeignCurrencyExchangeGainLoss602000.0
NetInvestmentPropertiesPurchaseAndSale-68 M-100 M78 M19 M-74 M-59 M-39 M-256 M272 M79 M
NetInvestmentPurchaseAndSale-68 M-100 M78 M19 M-74 M-59 M-39 M-256 M272 M79 M
NetPPEPurchaseAndSale-432000.0-621000.0-2 M-732000.0-4 M-43 M-21 M-15 M-23 M-20 M
Operating (gains) losses721000.0-341000.0-105000.0137000.03 M3 M4 M7 M321000.0941000.0
Other financing charges net67 M89 M13 M-776000.081 M216 M136 M-765000.0-3 M-2 M
Other investing changes net60000.0230000.0-2 M-3 M
Other non-cash items6 M9 M14 M15 M9 M16 M17 M22 M22 M29 M
PensionAndEmployeeBenefitExpense721000.0-341000.0-105000.0137000.03 M3 M4 M7 M373000.0941000.0
ProceedsFromStockOptionExercised15 M4 M9 M6 M124000.0
Purchase of property plant & equipment-432000.0-621000.0-2 M-732000.0-4 M-43 M-21 M-15 M-23 M-20 M
PurchaseOfInvestment-119 M-228 M-258 M-219 M-252 M-451 M-444 M-571 M-338 M-277 M
PurchaseOfLongTermInvestments-119 M-228 M-258 M-219 M-252 M-451 M-444 M-571 M-338 M-277 M
PurchaseOfPPE-432000.0-621000.0-2 M-732000.0-4 M-43 M-21 M-15 M-23 M-20 M
Revenue per share912000.01 M827000.0221000.0-673000.0-6 M969000.07 M11 M7 M
Sale of Float term investments51 M7 M2 M
Sale of short term investments51 M128 M338 M237 M179 M392 M405 M315 M603 M355 M
SaleOfInvestment51 M128 M338 M237 M179 M392 M405 M315 M610 M357 M
StockBasedCompensation6 M9 M12 M15 M9 M15 M19 M26 M33 M32 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University